Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors

Human Pathology

Volumn 31, Issue 5, 2000, Pages 593-600

  Roger, Pascal ^a,b,c,d,e,f   Daubes, Jean Pierre ^a,b,c,d,e,f   Maudelonde, Thierry ^a,b,c,d,e,f   Pignodel, Christine ^a,b,c,d,e,f   Gleizes, Michel ^a,b,c,d,e,f   Chapelle, Jean ^a,b,c,d,e,f   Marty Double, Christiane ^a,b,c,d,e,f   Baldet, Pierre ^a,b,c,d,e,f   Mares, Pierre ^a,b,c,d,e,f   Laffargue, François ^a,b,c,d,e,f   Rochefort, Henri ^a,b,c,d,e,f  

^a INSERM   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c UNIV MONTPELLIER   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

^e Hopital Gaston Doumergue   (France)

^f DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Benign breast disease; Carcinogenesis; Cathepsin D; Estrogen receptor; Mammary carcinoma in situ

Indexed keywords

ANTIESTROGEN; CATHEPSIN D; ESTROGEN; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CARCINOMA IN SITU; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROTEIN EXPRESSION;

EID: 0034067981     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hp.2000.6687     Document Type: Article

References (38)

1. Vogelstein B. Kinzler K.W. The multistep nature of cancer Trends Genet 9 1993 138 141
2. King M.C. Rowell S. Love S.M. Inherited breast and ovarian cancer: What are the risks? JAMA 269 1993 1975 1980
3. Dupont W.D. Page D.L. Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312 1985 146 151
4. Page D.L. Dupont W.D. Anatomic markers of human premalignancy and risk of breast cancer Cancer 66 1990 1326 1335
5. Pike M.C. Krailo M.D. Henderson B.E. “Hormonal” risk factors, “breast tissue age” and the age-incidence of breast cancer Nature 303 1983 767 770
6. Lacassagne A. Hormonal pathogenesis of adenocarcinoma of the breast Am J Cancer 27 1936 217 225
7. Rochefort H. Coezy E. Joly E. Hormonal control of breast cancer in cell culture King R.J.B. Lindner H.R. Lippman M. Hormones and Cancer 1980 Raven Press New York, NY 21 29
8. Dickson R.B. MacManaway M.E. Lippman M.E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth Science 232 1986 1540 1544
9. McGuire W.L. Hormone receptor: Their role in predicting prognosis and response to endocrine therapy Semin Oncol 5 1978 2428 2433
10. Korach K.S. Insights from the study of animals lacking functional estrogen receptor Science 266 1994 1524 1527
11. Cavaillès V. Garcia M. Rochefort H. Regulation of cathepsin D and pS2 gene expression by growth factors in MCF7 human breast cancer cells Mol Endocrinol 3 1989 552 558
12. Rochefort H. Editorial: The prognostic value of cathepsin D in breast cancer: A long road to the clinic Eur J Cancer 32A 1996 7 8
13. Ferrandina G. Scambia G. Bardelli F. Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: A meta-analysis Br J Cancer 76 1997 661 666
14. Jacquemier J.D. Rolland P.H. Vague D. Relationship between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast Cancer 49 1982 2534 2536
15. Khan S.A. Rogers M.A.M. Khurana K.K. Estrogen receptor expression in benign breast epithelium and breast cancer risk J Natl Cancer Inst 89 1997 37 42
16. Garcia M. Salazar-Retana G. Pages A. Distribution of the Mr 52,000 estrogen regulated protein in benign breast diseases an other tissues by immunohistochemistry Cancer Res 46 1986 3734 3786
17. Silverstein M.J. Poller D.N. Waisman J.R. Prognostic classification of breast ductal carcinoma in situ Lancet 345 1995 1154 1157
18. Consensus conference on the classification of ductal carcinoma in situ Hum Pathol 28 1997 1221 1225
19. Roger P. Montcourrier P. Maudelonde T. Cathepsin D Immunostaining in paraffin-embedded breast cancer cells and macrophages: Correlation with cytosolic assay Hum Pathol 25 1994 863 871
20. Garcia M. Capony F. Derocq D. Characterization of monoclonal antibodies to estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells Cancer Res 45 1985 709 716
21. Al Saati T. Clamens S. Cohen-Knafo E. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER) Int J Cancer 55 1993 651 654
22. Goulding H. Pinder S. Cannon P. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples Hum Pathol 26 1995 291 294
23. Maudelonde T. Brouillet J.P. Roger P. Immunostaining of cathepsin D in breast cancer: Quantification by computerised image analysis and correlation with cytosolic assay Eur J Cancer 28A 1992 1686 1691
24. Rochefort H. Cathepsin D in breast cancer: A tissue marker associated with metastasis Eur J Cancer 28A 1992 1780 1783
25. Pujol P. Daures J.P. Brouillet J.P. Timing at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer Br J Cancer 79 1999 909 914
26. Holland P.A. Knox W.F. Potten C.S. Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast J Natl Cancer Inst 89 1997 1059 1065
27. Barnes R. Masood S. Potential value of hormone receptor assay in carcinoma in situ of breast Am J Clin Pathol 94 1990 533 537
28. Fisher B. Dignain J. Wolmark N. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1999 1993 2000
29. Westley R. Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines Cell 20 1980 353 362
30. Van der Vijver M.J. Peterse J.L. Mooi W.J. NEU-protein overexpression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer N Engl J Med 319 1988 1239 1245
31. Rochefort H. Liaudet-Coopman E. Cathepsin D in cancer metastasis: A protease and a ligand APMIS 107 1999 86 95
32. Rochefort H. Cavaillès V. Augereau P. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer J Steroid Biochem 34 1989 177 182
33. Lakhani S.R. The transition from hyperplasia to invasive carcinoma of the breast J Pathol 187 1999 272 278
34. Tabar L. Fagerberg G. Chen H.H. Tumor development, histology and grade of breast cancers: Prognosis and progression Int J Cancer 66 1996 413 419
35. Nandi S. Guzman R.C. Yang Y. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis Proc Natl Acad Sci USA 92 1995 3650 3657
36. Gupta S.K. Douglas-Jones A.G. Fenn N. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ) Cancer 80 1997 1740 1745
37. Roylance R. Gorman P. Harris W. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer Cancer Res 59 1999 1433 1436
38. Fisher B. Costantino J.P. Wickerham D.L. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 90 1998 1371 1388